BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23624922)

  • 1. SPROUTY2 is a β-catenin and FOXO3a target gene indicative of poor prognosis in colon cancer.
    Ordóñez-Morán P; Irmisch A; Barbáchano A; Chicote I; Tenbaum S; Landolfi S; Tabernero J; Huelsken J; Muñoz A; Pálmer HG
    Oncogene; 2014 Apr; 33(15):1975-85. PubMed ID: 23624922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
    J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
    Dehner M; Hadjihannas M; Weiske J; Huber O; Behrens J
    J Biol Chem; 2008 Jul; 283(28):19201-10. PubMed ID: 18487207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 protein.
    Gao X; Hicks KC; Neumann P; Patel TB
    PLoS One; 2017; 12(2):e0171616. PubMed ID: 28196140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity.
    Barbáchano A; Ordóñez-Morán P; García JM; Sánchez A; Pereira F; Larriba MJ; Martínez N; Hernández J; Landolfi S; Bonilla F; Pálmer HG; Rojas JM; Muñoz A
    Oncogene; 2010 Aug; 29(34):4800-13. PubMed ID: 20543868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells.
    Liu H; Yin J; Wang H; Jiang G; Deng M; Zhang G; Bu X; Cai S; Du J; He Z
    Cell Signal; 2015 Mar; 27(3):510-8. PubMed ID: 25578861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: Correlation with the clinical stage of the disease.
    Feng YH; Wu CL; Tsao CJ; Chang JG; Lu PJ; Yeh KT; Uen YH; Lee JC; Shiau AL
    Cancer Biol Ther; 2011 Jan; 11(1):111-21. PubMed ID: 21099344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C ζ is a positive modulator of canonical Wnt signaling pathway in tumoral colon cell lines.
    Luna-Ulloa LB; Hernández-Maqueda JG; Santoyo-Ramos P; Castañeda-Patlán MC; Robles-Flores M
    Carcinogenesis; 2011 Nov; 32(11):1615-24. PubMed ID: 21859831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/β-catenin signaling regulates follicular development by modulating the expression of Foxo3a signaling components.
    Li L; Ji SY; Yang JL; Li XX; Zhang J; Zhang Y; Hu ZY; Liu YX
    Mol Cell Endocrinol; 2014 Feb; 382(2):915-25. PubMed ID: 24246780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150.
    Barbáchano A; Fernández-Barral A; Pereira F; Segura MF; Ordóñez-Morán P; Carrillo-de Santa Pau E; González-Sancho JM; Hanniford D; Martínez N; Costales-Carrera A; Real FX; Pálmer HG; Rojas JM; Hernando E; Muñoz A
    Oncogene; 2016 Jun; 35(23):2991-3003. PubMed ID: 26455323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sprouty2 protein enhances the response to gefitinib through epidermal growth factor receptor in colon cancer cells.
    Feng YH; Tsao CJ; Wu CL; Chang JG; Lu PJ; Yeh KT; Shieh GS; Shiau AL; Lee JC
    Cancer Sci; 2010 Sep; 101(9):2033-8. PubMed ID: 20624167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNMT3B overexpression by deregulation of FOXO3a-mediated transcription repression and MDM2 overexpression in lung cancer.
    Yang YC; Tang YA; Shieh JM; Lin RK; Hsu HS; Wang YC
    J Thorac Oncol; 2014 Sep; 9(9):1305-15. PubMed ID: 25122426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription Factor FOXO3a Overexpression Inhibits the Progression of Neuroblastoma by Regulating the miR-21/SPRY2/ERK Axis.
    Chen J; Xu Y; Wu P; Chen X; Weng W; Li D
    World Neurosurg; 2022 Aug; 164():e99-e112. PubMed ID: 35405317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
    Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
    Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis.
    Sarkar M; Khare V; Guturi KK; Das N; Ghosh MK
    Oncogene; 2015 Nov; 34(47):5843-56. PubMed ID: 25745998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sprouty2 inhibits amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.
    Cheng JC; Chang HM; Xiong S; So WK; Leung PC
    Oncotarget; 2016 Dec; 7(49):81645-81660. PubMed ID: 27835572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer.
    Wang S; Dong Y; Zhang Y; Wang X; Xu L; Yang S; Li X; Dong H; Xu L; Su L; Ng SS; Chang Z; Sung JJ; Zhang X; Yu J
    Oncogene; 2015 May; 34(20):2575-85. PubMed ID: 25023701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DBC1 regulates Wnt/β-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer.
    Kim HJ; Moon SJ; Kim SH; Heo K; Kim JH
    Cell Death Dis; 2018 Aug; 9(8):831. PubMed ID: 30082743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.